The KOSPI 200 is a benchmark index representing the top 200 most valuable companies listed on the Korea Exchange (KRX), South Korea's primary stock market. It is also a market-capitalization-weighted index. According to Bloomberg, the KOSPI 200's stocks make up “93% of the total market value of the Korea Stock Exchange.”
The KOSPI 200 is composed of a diverse range of sectors, with the top names in the index also being the biggest companies in the broader KOSPI.
KOSPI 200 Price, Chart & Dividend Yield
Launched in 1990 with a base value of 100, the KOSPI 200 is considered a more concentrated representation of the South Korean stock market compared to the broader KOSPI Composite. It is often used as a proxy for the performance of the South Korean economy and is a popular benchmark for investors and analysts seeking to track the performance of the country's largest and most influential companies.
As expected, the KOSPI 200 has moved similarly to the KOSPI, however, it has seen a slightly larger rise, climbing around 2.8% so far this year (as of August 26, 2024). Nevertheless, given the names included in the more concentrated index, some investors may have expected a stronger performance. In the last 12 months it has risen over 12%, compared to the KOSPI's 7.7% increase.
Today's Movers – Top 30 KRX Stocks
KOSPI 200 Price Forecast
As investors, it is important to understand both sides of the debate when assessing your investment options. Here are the bull and bear arguments for the KOSPI 200:
The Bull Argument: The KOSPI 200, as a concentrated index of the South Korean stock market's top 200 companies, benefits from the strengths of the South Korean economy. The country's technological advancements, particularly in semiconductors and electric vehicles, position it well for long-term growth. For example, if the semiconductor industry performs well, semiconductor companies in the index, such as SK Hynix, will perform well, therefore benefitting the overall KOSPI 200. In an April article, analysts at S&P Global noted that the “KOSPI 200 is better placed than Nikkei 225 in EPS/DPS, FCF/DPS and leveraged ratios, thus having more room to increase the dividends.”
The Bear Argument: While it is important to look for the positives, we also have to consider the bear arguments for the KOSPI 200 as there will, of course, be challenges. As mentioned in our page on the broader KOSPI index, issues, such as inflation, unemployment, and political uncertainties, could impact the South Korean stock market, while a slowdown in one of the primary industries served in the KOSPI 200 index — the semiconductor industry for example — could weigh on the performance.
Who Should Buy the KOSPI 200
The KOSPI 200, as a concentrated index of South Korea's top 200 companies, offers specific opportunities for investors:
Investors Seeking Focused South Korean Exposure: Those looking for more concentrated exposure to the South Korean stock market, specifically the largest and most influential companies, will find the KOSPI 200 attractive.
Technology and Semiconductor Investors: The KOSPI 200 is heavily weighted towards technology and semiconductor companies, reflecting South Korea's strength in these sectors. In April it was reported that the the market capitalisation ratio of semiconductors in the KOSPI 200 index hit a record high of 34.4%. Investors who believe in the long-term growth of Korean semiconductor and technology stocks may find the index appealing.
Automotive Investors: The index also includes several prominent South Korean automakers, making it a suitable option for those interested in the automotive sector.
Investors Seeking Growth Potential: South Korea's strong economy and large companies in well-known growth markets position the KOSPI 200 well. While the performance so far in 2024 has not been as many may have liked, investors may find index funds tracking the KOSPI 200 as attractively priced.
KOSPI 200 Top 10 Companies
Company | Market Cap (As of August 26, 2024) |
---|---|
Samsung | $380.64 Billion |
SK Hynix | $93.28 Billion |
LG Energy Solution | $66.71 Billion |
Samsung Biologics | $51.64 Billion |
Hyundai | $45.83 Billion |
Coupang | $41.02 Billion |
Celltrion | $32.08 Billion |
Kia | $30.38 Billion |
KB Financial Group | $25.14 Billion |
Shinhan Financial Group | $22.95 Billion |